For the Inventor, By the Inventor

Enter assignee name

New York, NY, United States of America

Bristol Meyers Squibb Company

USPTO Granted Patents = 41

Forward Citations = 415

Loading Chart...

Loading Chart...

162 inventors (with patents filed for the assignee):

John F Kadow (4 out of 136 patents)

Nicholas A Meanwell (3 out of 141 patents)

Tao Wang (3 out of 78 patents)

4. John N Feder (3 out of 67 patents)

5. Donald J P Pinto (2 out of 78 patents)

6. Kap-Sun Yeung (2 out of 54 patents)

7. George O Tora (2 out of 22 patents)

8. Katharine A Grant-Young (2 out of 24 patents)

9. Zhongxing Zhang (2 out of 64 patents)

10. Andrew P Degnan (2 out of 19 patents)

11. Jian Chen (2 out of 53 patents)

12. Chandra S Ramanathan (2 out of 33 patents)

13. Robert Michael Borzilleri (2 out of 60 patents)

14. Kin S Lam (2 out of 32 patents)

15. Grace A Hesler (2 out of 7 patents)

41 patents: Sort by Forward Citations

1. 11858979 - Fibronectin based scaffold domain proteins that bind PCSK9 (2024-01-02),

2. 10590105 - 1,3-dihydroxy-phenyl derivatives useful as immunomodulators (2020-03-17),

3. 10287295 - TGF-β inhibitors (2019-05-14),

4. 9840511 - 2-(aryl or heteroaryl-)phenyl (AZA)benzofuran compounds for the treatment of hepatitis C (2017-12-12),

5. 9822112 - Heteroarylene-bridged benzodiazepine dimers, conjugates thereof, and methods of making and using (2017-11-21),

6. 9580420 - Process for the preparation of 4-(8-(2-chlorophenoxy)-[1,2,4]triazolo[4,3-a]pyridin-3-yl)bicyclo[2.2.1]heptan-1-ol and novel intermediates therefor (2017-02-28),

7. 9193725 - Cyclic hydrazine derivatives as HIV attachment inhibitors (2015-11-24),

8. 9133160 - Substituted benzimidazole and imidazopyridine compounds useful as CYP17 modulators (2015-09-15),

9. 8513428 - Process for preparing atazanavir bisulfate and novel forms (2013-08-20),

10. 8470854 - Lactam-containing compounds and derivatives thereof as factor XA inhibitors (2013-06-25),

11. 8454959 - Compositions monovalent for CD28 binding and methods of use (2013-06-04),

12. 8404672 - Substituted heterocyclic compounds (2013-03-26),

13. 8383821 - NK-1 and serotonin transporter inhibitors (2013-02-26),

14. 8354410 - Compounds for the treatment of hepatitis C (2013-01-15),

15. 8202881 - JAK2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer (2012-06-19),

Bristol Meyers Squibb Company is a global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. With a diverse portfolio of products and a commitment to research and development, Bristol Meyers Squibb is dedicated to changing the lives of patients around the world.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

41 Patents

#190 in New York, NY

#466 in New York

#8,156 in US

#16,191 in the World

New York, NY, United States of America

Bristol Meyers Squibb Company

Forward Citations = 415

162 inventors:

John F Kadow (4 out of 136 patents)

Nicholas A Meanwell (3 out of 141 patents)

Tao Wang (3 out of 78 patents)

4. John N Feder (3 out of 67 patents)

5. Donald J P Pinto (2 out of 78 patents)

Please report any incorrect information to support@idiyas.com

Loading…